SCHEMBL25912095

SCHEMBL25912095

CCOC(=O)c1c(O)ccc2nc(-c3cnc(NC(C)C)n(C)c3=O)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LCK P06239 1/20 0.42
▸ CSF1R P07333 1/20 0.42
▸ PDGFRB P09619 1/20 0.42
▸ KIT P10721 1/20 0.42
▸ CYP2C9 P11712 1/20 0.42
▸ PDGFRA P16234 1/20 0.42
▸ FLT3 P36888 1/20 0.42
▸ PTK6 Q13882 1/20 0.42
▸ ADORA3 P0DMS8 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA2B P29275 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ KDM4E B2RXH2 2/20 0.35
▸ MAPT P10636 2/20 0.35
▸ ATM Q13315 1/20 0.35
▸ CA12 O43570 1/20 0.34
▸ CA1 P00915 1/20 0.34
▸ CA2 P00918 1/20 0.34
▸ CA7 P43166 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25912096 0.83 CSF1R (0.51) LCKCSF1RPDGFRBKITCYP2C9
SCHEMBL25912094 0.81 CSF1R (0.43) LCKCSF1RPDGFRBKITCYP2C9
SCHEMBL25910030 0.79 CSF1R (0.70) LCKCSF1RPDGFRBKITCYP2C9
SCHEMBL25911644 0.74 CSF1R (0.47) LCKCSF1RPDGFRBKITCYP2C9
SCHEMBL25317059 0.74 PDGFRB (0.47) LCKCSF1RPDGFRBKITCYP2C9
SCHEMBL25911715 0.72 CSF1R (0.43) LCKCSF1RPDGFRBKITCYP2C9
SCHEMBL25911369 0.71 CSF1R (0.45) LCKCSF1RPDGFRBKITCYP2C9
SCHEMBL25911557 0.70 PDGFRB (0.42) LCKCSF1RPDGFRBKITCYP2C9
SCHEMBL25911603 0.69 CSF1R (0.48) LCKCSF1RPDGFRBKITCYP2C9
SCHEMBL25319475 0.68 CSF1R (0.47) LCKCSF1RPDGFRBKITCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback